Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vakaramoko Diaby, Reem D. Almutairi, Aram Babcock, Richard K. Moussa & Askal Ali. (2021) Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews. Expert Review of Pharmacoeconomics & Outcomes Research 21:3, pages 353-364.
Read now
Read now
Articles from other publishers (2)
Alessandro G. Campolina, Tania Y. Yuba, Tassia C. Decimoni, Roseli Leandro, Maria del Pilar Estevez Diz, Hillegonda M. D. Novaes & Patrícia C. de Soárez. (2018) Health Economic Evaluations of Cancer in Brazil: A Systematic Review. Frontiers in Public Health 6.
Crossref
Crossref
Virginie Nerich, Sopany Saing, Eva Maria Gamper, Georg Kemmler, Franck Daval, Xavier Pivot & Bernhard Holzner. (2016) Cost–utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment 159:3, pages 407-424.
Crossref
Crossref